Jilin Guowen Hospital

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Liver and biliary tract cancer2 trials
• Stroke1 trial

Phase

• Phase 33 trials

Status

• Completed2 trials
• Active, not recruiting1 trial

Lead sponsor

• Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1 trial
• Shanghai Junshi Bioscience Co., Ltd.1 trial
• Tasly Biopharmaceuticals Co., Ltd.1 trial

Running trials

• Active, not recruiting

  A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)

  NCT04344158· Phase 3· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Source

Closed trials

• Completed

  rhPro-UK in Acute Ischaemic Stroke Within 4.5 Hours of Stroke Onset Trial 2(PROST-2)

  NCT05700591· Phase 3· Tasly Biopharmaceuticals Co., Ltd.· Source

• Completed

  Evaluate the Safety and Efficacy of Toripalimab Combined With Bevacizumab Versus Sorafenib Therapy for HCC

  NCT04723004· Phase 3· Shanghai Junshi Bioscience Co., Ltd.· Source